Every Wednesday Asa reviews interesting warning letters and other enforcement trends. He’s been writing this each week for 4+ years, and it is a labor of regulatory love.
We'll never share your email with anyone else. Cancel at any time.
This is a bizarre one. It involves a functional mushroom and herbal company that received a warning letter for claims made in clinical study and other citations in the “Newspaper” tab of its website. Typically, citations are not mentioned in warning letters unless they are ...
Greetings from SupplySide Connect! If you are attending, please stop by booth #723 and say hello. We have some fun ...
There have been only four eBay-related warning letters in recent years, and two of them occurred this week. This shows that ...
The NAD+ battles continue. In this National Advertising Division (NAD) competitor challenge case, several claims were challenged, and because the defending ...
Asa Waldstein is a 24-year veteran of the dietary supplement industry, with experience spanning manufacturing, marketing, and regulatory compliance. He is the principal of Apex Compliance, a software company dedicated to streamlining regulatory marketing compliance for the dietary supplement and natural products sectors. Asa also leads Supplement Advisory Group, a boutique consultancy focused on marketing risk analysis, labeling, and practical compliance strategies for websites and social media. Asa has helped oversee three FDA GMP inspections with no 483s and was honored with the 2023 AHPA Herbal Hero Award and the 2024 What's Up Supps Policy and Change Agent Award. He currently serves as Chair of the American Herbal Products Association’s (AHPA) Technology & AI Innovation Committee.
Upcoming Events
See Asa in person
